Corticosteroid response predicts bronchopulmonary dysplasia status at 36 weeks in preterm infants treated with dexamethasone: A pilot study.

Keith FeldmanChristopher R Nitkin Alain C CunaAlexandra OschmanWilliam E TruogMichael NorbergMichael F Nyp Jane B TaylorTamorah Lewis

Published in: Pediatric pulmonology (2022)

following dexamethasone administration were associated with downstream outcomes. Incorporating drug response phenotype into a BPD model may enable more rapid development of future therapeutics.

Keyphrases

preterm infants
low dose
high dose
low birth weight
small molecule
current status
emergency department
insulin resistance
gestational age
skeletal muscle
adverse drug
drug induced
quantum dots
sensitive detection